Global private equity and venture capital news and research

Private equity-backed Biomet settles bribery allegations $

27 Mar 2012

federal-court_lrgBiomet, the US medical giant taken private five years ago by a private equity consortium led by Blackstone, KKR, Goldman Sachs and TPG Capital, has paid $22m in charges to settle allegations that it bribed doctors in Argentina, Brazil, and China for nearly a decade to win business.

Sorry, you have reached your quota of 1 free article a week or you are attempting to read a Premium story.

To access the latest news and PREMIUM stories for FREE download the new AltAssets mobile app from the Google Play or App Store.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016